Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism α-synuclein inhibitors(Synuclein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H39N3O3 |
InChIKeyDZVFKWBBLHLLJQ-NDEPHWFRSA-N |
CAS Registry2893801-00-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 07 Feb 2023 |